LONDON (Reuters) Glivec, from Novartis, should not be used in patients who have had a gastrointestinal stromal tumor (GIST) removed by surgery, Britain's health cost watchdog said in draft guidance on Friday.The National Institute for Health and Clinical Excellence (NICE), which decides whether drugs should be paid for on the state-funded National Health Service, said there was a lack of evidenc
NEW YORK (Reuters) Swiss drugmaker Novartis AG won wider U.S approval for its leukemia drug Tasigna to treat a rare form of the blood cancer at an earlier stage of the disease, the Food and Drug Administration said on Thursday.Tasigna had previously been approved to treat adults with chronic myeloid leukemia, or CML, in patients who could not tolerate or were no longer responding to treatment w
NEW YORK (Reuters) Bristol-Myers Squibb's cancer drug Sprycel may be superior to the already highly effective standard medicine Gleevec in treating newly diagnosed patients with chronic myeloid leukemia, according to results of a clinical trial.Sprycel, known chemically as dasatinib, is currently approved to treat chronic myeloid leukemia (CML) patients who have become resistant to, or cannot to